Determination of a suitable voriconazole pharmacokinetic model for personalised dosing.

about

Optimizing Antipsychotic Patient Management Using Population Pharmacokinetic Models and Point-of-Care Testing.Pharmacokinetic Modeling of Voriconazole To Develop an Alternative Dosing Regimen in Children.

P2860

Q42363845-30DACA81-73E1-4456-AD4A-08FDAA949B8A Q47781187-74DCFA83-B51D-4009-9516-D9F1785E74C5

P2860

Determination of a suitable voriconazole pharmacokinetic model for personalised dosing.

Item

http://www.wikidata.org/entity/Q38931118

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Determination of a suitable voriconazole pharmacokinetic model for personalised dosing.

@en

type

Item

label

Determination of a suitable voriconazole pharmacokinetic model for personalised dosing.

@en

prefLabel

Determination of a suitable voriconazole pharmacokinetic model for personalised dosing.

@en

P1476

Determination of a suitable voriconazole pharmacokinetic model for personalised dosing.

@en

P2093

Bruce Green

http://www.w3.org/2001/XMLSchema#string

E Geoffrey Playford

http://www.w3.org/2001/XMLSchema#string

P2860

Basic Concepts in Population Modeling, Simulation, and Model-Based Drug Development

Population pharmacokinetic analysis of voriconazole plasma concentration data from pediatric studies.

In vitro hepatic metabolism explains higher clearance of voriconazole in children versus adults: role of CYP2C19 and flavin-containing monooxygenase 3

Bioavailability and population pharmacokinetics of voriconazole in lung transplant recipients.

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions.

Steady-state plasma pharmacokinetics of oral voriconazole in obese adults.

Pharmacokinetics of voriconazole administered concomitantly with fluconazole and population-based simulation for sequential use.

Population pharmacokinetics of voriconazole in adults

What is the best size descriptor to use for pharmacokinetic studies in the obese?

Integrated population pharmacokinetic analysis of voriconazole in children, adolescents, and adults.

P2888

s10928-015-9462-9

P304

165-177

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10928-015-9462-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jennifer Martin

David A J McDougall

P577

2015-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1047551543

http://www.w3.org/2001/XMLSchema#string

P698

26676909

http://www.w3.org/2001/XMLSchema#string

Determination of a suitable voriconazole pharmacokinetic model for personalised dosing.

about

P2860

P2860

Determination of a suitable voriconazole pharmacokinetic model for personalised dosing.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698